Call 954-525-8155 to schedule a FREE consultation.
Mass Torts or Drugs and Medical Devices
Beck & Haggerty represents victims of defective medical devices and pharmaceutical drugs that suffer side effects of which the manufacturer fails to warn.
On August 4, 2011, the U.S. Food and Drug Administration (FDA) approved added warnings on the label of the Type II diabetes medication Actos, after reporting that its sole ingredient, pioglitazone, may increase the risk of bladder cancer. Since that time, numerous studies have confirmed the increased risk of developing bladder cancer.
In July 2011, after receiving a large volume of adverse event reports relating to transvaginal mesh, the FDA issued a Safety Alert stating that it was unclear if the “mesh is more effective than traditional non-mesh repair and it may expose patients to greater risk.” Since that time, thousands of lawsuits have been filed wherein Plaintiffs allege serious injuries including pelvic pain, erosion, infection, painful intercourse, perforation of the bowel or bladder and the need for corrective surgery.
Mirena Intrauterine Device
In December 2009, the FDA issued a warning letter stating that Bayer’s marketing and advertising of Mirena “overstates the efficacy of Mirena, presents unsubstantiated claims, minimizes the risks of using Mirena and includes false or misleading presentations regarding Mirena.”
Some of the risks associated with Mirena include abcesses, infertility, embedment in the uterus, erosion of adjacent areas such as the vagina, uterine perforation, and pelvic inflammatory disease.
Yaz/Yasmin Birth Control
On September 26, 2011, the FDA released a Safety Communication reporting that it “remained concerned” about the increased risk of blood clots associated with the use of drospirenone-containing birth control pills such as Yaz and Yasmin. From 2009 – 2011, there were over seven published studies finding drospirenone significantly increases the risk of blood clots in women. As of October 15, 2012, there were over 12,000 Yaz/Yasmin lawsuits pending in the United States involving women who suffered from blood clots or pulmonary embolism.
On December 7, 2011, the FDA issued a Safety Communication reporting that it was investigating reports of serious and fatal bleeds in patients taking Pradaxa. Pradaxa quickly become a controversial medication once researchers found that in the event of a traumatic hemorrhage in patients taking Pradaxa, there currently aren’t any effective reversal agents.
Metal on Metal Hip Implants
Metal hip implants, which have been found to release particles of the chromium-cobalt alloy as the metal parts wear against each other and also suffer increased failure rates, include Johnson & Johnson’s DePuy ASR and Pinnacle; Smith and Nephew’s Birmingham; Zimmer’s Durom; Wright Conserve; and Wright Profemur.
Mass tort claims are taken on a contingency basis, so there is no fee unless there is a recovery.
If you or a loved one has suffered from any of these pharmaceutical drugs or medical devices, contact us today for a free, confidential consultation.